Glenmark Life Sciences declined 2% to Rs 858.20 after the company’s standalone net profit declined 17.69% to Rs 111.48 core in Q1 FY25 as compared with Rs 135.45 crore in Q1 FY24.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
